Abstract
CA 19-9 is a marker correlated to the clinical evolution of pancreatic adenocarcinoma. To analyze the clinical value of pre- and postoperative CA 19-9 serum levels in stage I and II pancreatic cancer. We analyzed 61 patients resected for pancreatic cancer. Patients were evaluated about the pre-operative CA 19-9 values and then divided into 3 groups: high, high-low and low, on the basis of pre- and postoperative CA 19-9 levels. The correlations between these groups and age, sex, pT, pN, tumor stage, jaundice, surgical radicality, tumor size, number of harvested and positive lymph nodes, grading, overall and major morbidities and post-operative mortality together with survival rates were analyzed. Higher values of pre-operative CA 19-9 were significantly correlated to the presence of jaundice, high pT, pN, stage and higher number of metastatic lymph nodes. In 49 patients (80.3 %) an R0 resection was performed. Five-year overall survival (OS) and disease free survival (DFS) were significantly better in patients with high levels of pre-operative CA 19-9, even in R0 cases. After stratification, 30 patients were included in the high group, 13 in the high-low group and 18 in the low group. A statistically significant correlation was f...Continue Reading
References
Apr 1, 1992·Annals of Surgery·F TianJ M Howard
Apr 3, 1981·Science·H KoprowskiH F Sears
Nov 21, 1997·Annals of Surgical Oncology·R C MontgomeryB L Eisenberg
Aug 7, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J M Rhodes
Jun 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cristina R FerroneAndrew L Warshaw
Nov 14, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·K S Goonetilleke, A K Siriwardena
Nov 26, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adam C BergerChristopher G Willett
Apr 21, 2009·American Journal of Surgery·Daniele MarrelliFranco Roviello
Jan 9, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Marsha E ReichmanBrenda K Edwards
Mar 26, 2010·Annals of Surgical Oncology·Naru KondoTaijiro Sueda
Nov 3, 2010·Annals of Surgical Oncology·Sherif R Z Abdel-MisihMark Bloomston
Aug 25, 2011·Annals of Surgical Oncology·Shojiro HataTomoo Kosuge
Sep 20, 2011·Journal of Visceral Surgery·C NeuzilletP Hammel
Nov 8, 2011·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·V M BanzD F Mirza
Jan 14, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J L HumphrisUNKNOWN NSW Pancreatic Cancer Network
Mar 14, 2012·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Teiichi SugiuraAtsuyuki Maeda
May 9, 2012·World Journal of Surgical Oncology·Kun-Chun ChiangMiin-Fu Chen
Sep 22, 2012·International Journal of Clinical Oncology·Faruk TasIbrahım Yıldız
Dec 19, 2012·Annals of Surgical Oncology·Werner HartwigJens Werner
Apr 9, 2013·Annals of Surgical Oncology·Richard J Bold
Nov 8, 2013·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Majid A AlmadiAbdulrahman M Aljebreen
Dec 21, 2013·Gastroenterology·Mahmoud M Al-HawaryDiane M Simeone
Jun 4, 2014·World Journal of Surgical Oncology·Qian DongXiu-juan Qu
Citations
Jul 15, 2017·Tumori·Aldo SainatoFabiola Paiar
Jan 19, 2017·Oncotarget·Xiaoyu LiZibin Tian
Jan 25, 2019·Oncology Letters·Nobuyuki NishizawaKeishi Yamashita
Aug 15, 2019·Journal of Clinical Medicine·Morgan Bonds, Flavio G Rocha
May 23, 2018·Annals of Surgical Oncology·Caroline J RieserMelissa E Hogg
Sep 14, 2020·Annals of Surgical Oncology·Friedrich AngerStefan Löb
May 29, 2021·Frontiers in Oncology·Roman O KowalchukKenneth W Merrell